We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
4 own
18 watching
Current Price
$2.1
$-0.03
(-1.64%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
91.74M
52-Week High
8.73
52-Week Low
1.98
Average Volume
0.03M
Dividend Yield
--
P/E Ratio
--
Market Capitalization91.74M
52-Week High8.73
52-Week Low1.98
Average Volume0.03M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
PR Newswire
2 months ago
Thinking about buying stock in Store Capital, AMTD Idea Group, Phunware, Fusion Pharmaceuticals, or Aditxt? Thinking about buying stock in Store Capital, AMTD Idea Group, Phunware, Fusion Pharmaceuticals, or Aditxt? PR Newswire NEW YORK, Sept. 15, 2022 NEW YORK, Sept. 15, 2022 /PRNewswire...
CNW Group - News Releases
2 months ago
Fusion Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Fusion Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Canada NewsWire HAMILTON, ON and BOSTON, Sept. 7, 2022 HAMILTON, ON and BOSTON, Sept. 7, 2022 /CNW...
PR Newswire
2 months ago
Fusion Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Fusion Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference PR Newswire HAMILTON, ON and BOSTON, Sept. 7, 2022 HAMILTON, ON and BOSTON, Sept. 7, 2022 /PRNewswire...
CNW Group - News Releases
3 months ago
Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of FPI-1966 In Patients with Advanced Solid Tumors Expressing FGFR3 Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of FPI-1966 In Patients with Advanced Solid Tumors Expressing FGFR3 Canada NewsWire...
PR Newswire
3 months ago
Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of FPI-1966 In Patients with Advanced Solid Tumors Expressing FGFR3 Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of FPI-1966 In Patients with Advanced Solid Tumors Expressing FGFR3 PR Newswire...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$2.1
$-0.03
(-1.64%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00